about
Omics-based identification of biomarkers for nasopharyngeal carcinomaRadiotherapy combined docetaxel and oxaliplatin chemotherapy is effective in patients with locally advanced nasopharyngeal carcinoma.miR-185-3p regulates the invasion and metastasis of nasopharyngeal carcinoma by targeting WNT2B in vitro.BMP2 promotes proliferation and invasion of nasopharyngeal carcinoma cells via mTORC1 pathwayIndole-3-carbinol inhibits nasopharyngeal carcinoma cell growth in vivo and in vitro through inhibition of the PI3K/Akt pathwayParametric contrast-enhanced ultrasound as an early predictor of radiation-based therapeutic response for lymph node metastases of nasopharyngeal carcinoma.Plasma microRNA profiling in nasopharyngeal carcinoma patients reveals miR-548q and miR-483-5p as potential biomarkers.Combination of autoantibodies against NY-ESO-1 and viral capsid antigen immunoglobulin A for improved detection of nasopharyngeal carcinoma.Factors determining the survival of nasopharyngeal carcinoma with lung metastasis alone: does combined modality treatment benefit?Monoacylglycerol lipase promotes metastases in nasopharyngeal carcinoma.Down-regulation of FoxM1 by thiostrepton or small interfering RNA inhibits proliferation, transformation ability and angiogenesis, and induces apoptosis of nasopharyngeal carcinoma cells.Overexpression of FOXM1 is associated with metastases of nasopharyngeal carcinomaPhosphorylated Mnk1 and eIF4E are associated with lymph node metastasis and poor prognosis of nasopharyngeal carcinoma.Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cellsA recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancer.Prognosticators and risk grouping in patients with lung metastasis from nasopharyngeal carcinoma: a more accurate and appropriate assessment of prognosisTherapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin.MiR-223 targeting MAFB suppresses proliferation and migration of nasopharyngeal carcinoma cells.Secreted protein acidic and rich in cysteine (SPARC) is associated with nasopharyngeal carcinoma metastasis and poor prognosis.Identification of Four-Jointed Box 1 (FJX1)-Specific Peptides for Immunotherapy of Nasopharyngeal Carcinoma.Loss of epithelial membrane protein-2 expression confers an independent prognosticator in nasopharyngeal carcinoma: a cohort study.Unusual coexistence of extramedullary plasmacytoma and nasopharyngeal carcinoma in nasopharynxPrognostic value of MRI-derived masticator space involvement in IMRT-treated nasopharyngeal carcinoma patientsQuantification of Epstein-Barr virus DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern China.Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy.The prognosis of nasopharyngeal carcinoma involving masticatory muscles: a retrospective analysis for revising T subclassifications.Recurrent FGFR3-TACC3 fusion gene in nasopharyngeal carcinomaHigh Expression of FGFR4 Enhances Tumor Growth and Metastasis in Nasopharyngeal Carcinomaγ-secretase inhibition combined with cisplatin enhances apoptosis of nasopharyngeal carcinoma cellsDistant metastasis risk and patterns of nasopharyngeal carcinoma in the era of IMRT: long-term results and benefits of chemotherapy.ZNF488 Enhances the Invasion and Tumorigenesis in Nasopharyngeal Carcinoma Via the Wnt Signaling Pathway Involving Epithelial Mesenchymal Transition.Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinomaCorrelation between pretreatment serum LDL-cholesterol levels and prognosis in nasopharyngeal carcinoma patients.Protein tyrosine kinase 6 is associated with nasopharyngeal carcinoma poor prognosis and metastasis.Risk stratification based on change in plasma Epstein-Barr virus DNA load after treatment in nasopharyngeal carcinomaScavenger receptor B1 is a potential biomarker of human nasopharyngeal carcinoma and its growth is inhibited by HDL-mimetic nanoparticles.Overexpression of the PSAT1 Gene in Nasopharyngeal Carcinoma Is an Indicator of Poor PrognosisUBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathwayExploration and Validation of C-Reactive Protein/Albumin Ratio as a Novel Inflammation-Based Prognostic Marker in Nasopharyngeal Carcinoma.Overweight/obese status associates with favorable outcome in patients with metastatic nasopharyngeal carcinoma: a 10-year retrospective study.
P2860
Q28082480-0F73082E-DD90-4629-906A-972AF58E5D81Q33426763-5E4DEC3B-CA2A-42D5-B153-BCD87B2422F2Q33599027-1642AC00-9DB2-4DE0-BB15-57E97F4654DFQ33657520-DF5E2751-C515-4F37-9487-04654A81B02CQ33769512-56954BB7-FD82-48CF-8F3E-63ED5D165E62Q33933009-BB5F8706-BE6C-46B0-AEC1-758E94F18589Q33947851-D1D6CE76-A9B6-41DC-9867-F9ECF9FD2E3EQ33967422-7F2C6E01-F480-4B58-BCA6-3BFE21C735D2Q34001937-A37EB28B-2C93-4268-862D-A2B9B70E5344Q34028928-D6D3DB64-A8AE-4636-90DD-688642A31EDAQ34371119-1DFF490F-CA32-4552-B1AC-86A38117D07CQ34589178-891CFE87-7DD5-4654-AE14-FB0C9C7B955DQ35097767-5FFF6937-3D4E-4E2E-83DA-DAB937CEAD13Q35119824-6A69BE93-E824-4E9A-B323-8E9DF83E2EA6Q35121627-F37F4B04-7669-4B43-85C5-E61303FE06D5Q35231227-C6D80604-29DD-4F4A-8D10-284E542C3127Q35505126-433ADA12-5672-4930-A788-1A450C0B6BE3Q35657534-5F2FBA49-8C92-4E2C-BB88-E1D5F8229675Q35812137-9F866F92-483B-43FE-AB6F-D16CE21E1292Q35832185-6AD3AC31-D81B-47FA-883F-04BB8BB0A340Q35882003-2E5DBB65-C49F-4BD1-9A11-D89924736F53Q36071056-1D0871A2-B9D3-4243-BAF7-03A8804278C6Q36092475-884AB06B-66A1-48FD-BFCB-A164D1B738F0Q36092875-DCFE4414-C6EB-45BF-95D2-79DE0CC0CD8AQ36109579-A7492A52-6AB9-49E7-8D85-4391B9EEF1E5Q36153264-B84E8DDA-0BCD-4E81-823C-97F7B57097C7Q36211300-A0EBD189-62DF-40DE-9CEA-7D44DFA36F95Q36214131-2BAF46FE-AE33-439B-B4A8-9ADECB8FA468Q36224427-47C88BE0-C32A-4F96-9D87-E9197BA83BABQ36414509-D07D7905-D892-403B-91C9-238D09EDFD31Q36482591-5A13D4DF-7C22-4131-ADA2-03BF5ECB6EAAQ36782643-BAB68A1F-31E1-4D65-82D7-2E9E57E0E1FDQ36883247-CAF90F8A-5D23-488B-93F6-0DBDA6652951Q36940726-AC7B05F7-F972-42D1-BF4E-931225B3B688Q36962686-CD878F7C-5FC8-43CD-8C44-36F530775647Q36997612-6EEF99C1-01FA-4124-8E7A-2A2FDC4CF3E8Q37015716-24206F7B-7BCD-4818-BC44-30143C59E7CFQ37046830-F313D1EA-4568-4A59-9B50-1D284EA25851Q37133633-423C357D-3928-49ED-A6EA-7DDA2CD8D3D6Q37160755-D6ADC88E-C917-4D82-A651-AA04C9F5F7C1
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nasopharyngeal carcinoma: the next challenges.
@en
Nasopharyngeal carcinoma: the next challenges.
@nl
type
label
Nasopharyngeal carcinoma: the next challenges.
@en
Nasopharyngeal carcinoma: the next challenges.
@nl
prefLabel
Nasopharyngeal carcinoma: the next challenges.
@en
Nasopharyngeal carcinoma: the next challenges.
@nl
P2093
P1476
Nasopharyngeal carcinoma: the next challenges.
@en
P2093
Albiruni R A Razak
Kelvin Chan
Lillian L Siu
P304
P356
10.1016/J.EJCA.2010.04.004
P577
2010-05-05T00:00:00Z